Pharma: In the clinic
Friday, July 25, 2014
Bayer AG, of Leverkusen, Germany, reported results from a phase III trial testing a 15 percent foam formulation of its azelaic acid (Aza) for the topical treatment of inflammatory papules and pustules of rosacea.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.